Svetlana Kuznetsova, PhD
Assistant Professor of Therapeutic RadiologyDownloadHi-Res Photo
Cards
Appointments
Therapeutic Radiology
Primary
Contact Info
About
Copy Link
Titles
Assistant Professor of Therapeutic Radiology
Biography
Dr. Svetlana Kuznetsova earned her B.Sc. and Ph.D. from the University of Calgary in Alberta, Canada. During her undergraduate studies, her Honors thesis delved into solid-state dosimeters at low kilovoltage energy ranges, focusing on their application in clinical settings. Her doctoral research centered on liver Stereotactic Body Radiation Therapy (SBRT), where she developed an approach for the quantification of geometric delivery accuracy. Her Ph.D. work resulted in numerous awards from National and International entities, such as Natural Science and Engineering Research Council of Canada, as well as International Organization of Medical Physics. Following the completion of Graduate Studies, her Ph.D. thesis was nominated for Governor General Gold Medal.
Dr. Kuznetsova was admitted to the Medical Physics Residency Program at the University of California, San Diego (UCSD). She successfully completed her residency in 2023 and subsequently joined Yale New Haven Hospital as a Medical Physicist. Furthermore, she holds an Assistant Professor position within the Department of Therapeutic Radiology at Yale School of Medicine.
Dr. Kuznetsova continues her work in the development and standardization of radiation oncology tools and methodologies.
Last Updated on January 24, 2024.
Appointments
Therapeutic Radiology
Assistant ProfessorPrimary
Other Departments & Organizations
- All Institutions
- Therapeutic Radiology
Education & Training
- Medical Physics Residency
- University of California, San Diego (2023)
- PhD
- University of Calgary, Medical Physics (2021)
- BSc (Hon)
- University of Calgary, Physics and Astronomy
Board Certifications
Therapeutic Medical Physics
- Certification Organization
- American Board of Radiology
- Original Certification Date
- 2025
Research
Copy Link
Research at a Glance
Publications Timeline
A big-picture view of Svetlana Kuznetsova's research output by year.
7Publications
20Citations
Publications
2024
Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost
Zhong A, Lui A, Kuznetsova S, Kallis K, Conlin C, Do D, Domingo M, Manger R, Hua P, Karunamuni R, Kuperman J, Dale A, Rakow-Penner R, Hahn M, van der Heide U, Ray X, Seibert T. Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: 1024-1031. PMID: 38925224, DOI: 10.1016/j.ijrobp.2024.06.007.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBiochemical failureClinical outcomesProstate tumorsRadiation therapyClinical impactProbability of biochemical failureKnowledge-based planning modelPhase III randomized controlled trialsAbsolute increaseContouring variabilityFocal radiation therapyInferior clinical outcomesProstate cancer outcomesPatient casesAccurate delineationBoost plansTumor boostFocal RTRT boostDiagnostic CTTarget volumeRadiation oncologistsCT simulationProspective studyTumor targeting
2023
Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost
Zhong A, Lui A, Kuznetsova S, Kallis K, Hussain T, Conlin C, Do D, Domingo M, Manger R, Hua P, Karunamuni R, Kuperman J, Dale A, Rakow-Penner R, Hahn M, Moore K, Ray X, Seibert T. Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost. International Journal Of Radiation Oncology • Biology • Physics 2023, 117: e455. DOI: 10.1016/j.ijrobp.2023.06.1644.Peer-Reviewed Original ResearchCitationsConceptsProbability of biochemical failureBiochemical failureRadiation oncologistsConventional MRITumor contoursRT planningTumor boostPatient casesRandomized phase III trialCase 2Disease-free survivalMetastasis-free survivalTissue constraintsPhase III trialsProstate cancer tumorsQuantitative MRI biomarkersBoost plansFocal radiotherapyDosimetric parametersProstate tumorsTarget volumeIII trialsProspective studyClinical impactProstate
2022
Auto-delineation framework for the focal liver reaction observed in post Stereotactic Body Radiation Therapy (SBRT) Primovist MRI scans.
Kuznetsova S, Grendarova P, Sinha R, Ploquin N, Thind K. Auto-delineation framework for the focal liver reaction observed in post Stereotactic Body Radiation Therapy (SBRT) Primovist MRI scans. Med Dosim 2022, 47: 1-7. PMID: 34376315, DOI: 10.1016/j.meddos.2021.06.005.Peer-Reviewed Original Research
2021
Direct visualization and correlation of liver stereotactic body radiation therapy treatment delivery accuracy with interfractional motion.
Kuznetsova S, Sinha R, Thind K, Ploquin N. Direct visualization and correlation of liver stereotactic body radiation therapy treatment delivery accuracy with interfractional motion. J Appl Clin Med Phys 2021, 22: 129-138. PMID: 34240556, DOI: 10.1002/acm2.13333.Peer-Reviewed Original Research
2019
Structure guided deformable image registration for treatment planning CT and post stereotactic body radiation therapy (SBRT) Primovist(®) (Gd-EOB-DTPA) enhanced MRI.
Kuznetsova S, Grendarova P, Roy S, Sinha R, Thind K, Ploquin N. Structure guided deformable image registration for treatment planning CT and post stereotactic body radiation therapy (SBRT) Primovist(®) (Gd-EOB-DTPA) enhanced MRI. J Appl Clin Med Phys 2019, 20: 109-118. PMID: 31755658, DOI: 10.1002/acm2.12773.Peer-Reviewed Original ResearchDosimetric and radiobiological impact of abdominal compression on adjacent gastro-intestinal critical structures for patients treated with upper and mid-abdominal stereotactic body radiotherapy.
Roy S, Kuznetsova S, Thind K, Grendarova P, Ploquin N, Sinha RS. Dosimetric and radiobiological impact of abdominal compression on adjacent gastro-intestinal critical structures for patients treated with upper and mid-abdominal stereotactic body radiotherapy. J Radiosurg SBRT 2019, 6: 139-151. PMID: 31641550.Peer-Reviewed Original Research
2018
Characterization of nanoDot optically stimulated luminescence detectors and high-sensitivity MCP-N thermoluminescent detectors in the 40-300 kVp energy range.
Poirier Y, Kuznetsova S, Villarreal-Barajas JE. Characterization of nanoDot optically stimulated luminescence detectors and high-sensitivity MCP-N thermoluminescent detectors in the 40-300 kVp energy range. Med Phys 2018, 45: 402-413. PMID: 29164632, DOI: 10.1002/mp.12691.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Honors
honor Postgraduate Scholarship - Doctoral
09/01/2020National AwardNatural Science and Engineering Research Council of Canada (NSERC)DetailsCanadahonor Best Oral Presentation Award at the World Congress on Medical Physics and Biomedical Engineering
06/08/2018International AwardInternational Organization of Medical Physics (IOMP)DetailsCzech Republic
Get In Touch
Copy Link